Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, has announced that two recent independent studies have confirmed that the company's pioneering DX-S offline detector system delivers high quality diagnostic exposures with significantly reduced patient exposure dose. A study by the University Clinical Center of Giessen and Marburg in Germany evaluated the dose and quality performance of Agfa HealthCare's DX-S system, compared to the performance of a 400 speed class screen/film system. The study involved 200 thoracic exposures from children. The second study, by the Friedrich Schiller University in Jena, Germany, covered larger children and adolescents and exposures using a chest phantom . The results were evaluated by five investigators. Both studies concluded that, with Agfa HealthCare's DX-S system, the dose could be reduced by up to 50 percent, without reducing the diagnostic quality.
"These are exciting results for us," states Iskandar Accaoui, Global Manager of the Digital Radiography Business Unit at Agfa HealthCare. "We have always known that our DX-S system has the capability to significantly reduce exposure dose. These studies reinforce the efforts of our research teams to deliver not only technologically-pioneering digital radiography solutions, but also systems that offer a clear benefit to the patient."
Agfa HealthCare's advanced DX-S system is a groundbreaking system that has created a new threshold in Digital Radiography. It includes DirectriX needle-based detector technology, that offers increased image quality and potential for X-ray patient dose reduction, and Scanhead technology for reduced waiting times. The system fills the gap in the current range of Digital Radiography Solutions, by providing a unique combination of image quality, speed and flexibilitythat exceeds traditional Computed Radiography (CR) solutions.It is used in environments where patient comfort, exam speed and imaging flexibility are of paramount importance. The DX-S is a leading alternative to DR (Direct Radiography) in all of the environments listed. It provides the flexibility and economical advantages of CR, with the quality of DR.
Related news articles:
- Agfa HealthCare's Profile
About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,283 million Euro in 2007.
About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales. For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.